Your browser doesn't support javascript.
loading
Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI).
Tuyls, Sebastiaan; Van Der Brempt, Xavier; Faber, Margaretha; Gadisseur, Romy; Dezfoulian, Bita; Schrijvers, Rik; Froidure, Antoine.
Afiliação
  • Tuyls S; Pulmonology Department, Sint Augustinus Ziekenhuis GZA, Antwerpen and UZ Leuven, Leuven, Belgium.
  • Van Der Brempt X; Pulmonology Department and Allergopôle, Clinique Saint-Luc, Bouge, Belgium.
  • Faber M; Allergology and Immunology Department, World Allergy Organization (WAO) Center of Excellence, Universitaire Ziekenhuizen Antwerpen and Universiteit Antwerpen, Antwerpen, Belgium.
  • Gadisseur R; Clinical Biology Department, CHU Liège and Université de Liège, Liège, Belgium.
  • Dezfoulian B; Dermatology Department, CHU Liège and Université de Liège, Liège, Belgium.
  • Schrijvers R; KU Leuven Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, KU Leuven, Leuven, Belgium.
  • Froidure A; Pulmonology Department, WAO Center of Excellence, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
Acta Clin Belg ; 77(3): 552-557, 2022 Jun.
Article em En | MEDLINE | ID: mdl-33792500

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hipersensibilidade / Anafilaxia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hipersensibilidade / Anafilaxia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article